Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Fri, 23.05.2025
The Platform Group AG
The Platform Group AG: Q1 figures with significant increase in GMV, sales and profit
GMV grows by 86.9% to EUR 356.3 million (3M 2024: EUR 190.6 million)
Net sales increase by 49.0% to EUR 160.8 million (3M 2024: EUR 107.9 million)
EBITDA (adjusted) up 87.1% to EUR 15.9 million (3M 2024: EUR 8.5 million)
EBITDA (reported) grows by 17.4% to EU [ … ]
Fri, 23.05.2025
NFON AG
Company Name:
NFON AG
ISIN:
DE000A0N4N52
Reason for the research:
Update
Recommendation:
BUY
from:
23.05.2025
Target price:
EUR 12.30
Target price on sight of:
12 months
Last rating change:
Analyst:
Philipp Sennewald
More to come after solid start into the year; chg.
Q1’25 sales increased by 4.0% yoy to € 22.1m (eNu [ … ]
Fri, 23.05.2025
Siam Cement Group
EQS Newswire / 23/05/2025 / 09:00 CET/CEST
BANGKOK, THAILAND - Media OutReach Newswire - 23 May 2025 - SCG successfully co-hosted INTERCEM Asia 2025, the world's premier cement industry conference, welcoming over 1,000 leaders from 52 countries. This co-hosting opportunity marks a strategic milestone in SCG's international business development [ … ]
Fri, 23.05.2025
Alzchem Group AG
Alzchem Group AG successfully completes long-term succession planning for its Management Board: Supervisory Board appoints Dr. Jürgen Sans as Chief Operating Officer with effect from 1 January 2026
Trostberg, May 23, 2025 – Alzchem Group AG, a global specialty chemicals company, has successfully completed its long-term succession planning for the [ … ]
Fri, 23.05.2025
Secarna Pharmaceuticals GmbH & Co. KG
Secarna Pharmaceuticals to present new data and clinical strategy for lead antisense oligonucleotide program SECN-15 at ASCO 2025
Data support that targeting NRP1 with antisense oligonucleotides is a promising therapeutic strategy for solid cancers where current immunotherapies show limited benefit
SECN-15 demonstrates meaningful anti-tumor activ [ … ]
Fri, 23.05.2025
Brödernas Group AB
May 23, 2025, 09.00 CET
Brödernas Group AB (publ) delays the publication of the annual audited consolidated financial statements of the Group due in April 2025
Reference is made to Brödernas Group AB (publ) ("Brödernas"), SEK 175,000,000 senior secured callable fixed rate bonds with ISIN NO0013250597 ("Existing Bonds").
Brödernas has, in accorda [ … ]
Fri, 23.05.2025
Grand City Properties S.A.
THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAWS OR REGULATIONS
GRAND CITY PROPERTIES S.A. ANNOUNCES PUBLICATION OF CONVENING NOTICE FOR THE 2025 A [ … ]
Fri, 23.05.2025
Aroundtown SA
THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAWS OR REGULATIONS
AROUNDTOWN ANNOUNCES PUBLICATION OF CONVENING NOTICE FOR THE 2025 ANNUAL GENERAL MEE [ … ]
Fri, 23.05.2025
Aquis Stock Exchange
ANNOUNCEMENT OF APPLICATION FOR ADMISSION TO THE AQUIS GROWTH MARKET
APPLICANT NAME:
Ajax Resources plc
APPLICANT REGISTERED OFFICE, PRINCIPAL PLACE OF BUSINESS (IF DIFFERENT) AND TELEPHONE NUMBER:
Salisbury House, London Wall, London, United Kingdom, EC2M 5PS
+44208 [ … ]
Fri, 23.05.2025
Curatis Holding AG
Ad hoc announcement pursuant to Art. 53 LR
Liestal, Switzerland, 23 May 2025: An epidemiological market study commissioned by Curatis Holding AG (SIX:CURN, “Curatis”) shows that the target patient group is substantially larger than previous estimates. In the US alone, over 150,000 patients suffer from peritumoral brain edema (PTBE) in association w [ … ]